| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Australia | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Environmental technology | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Climate change adaptation technologies | |
| #5 | Animal care | |
| #6 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chang Lung-Ji | 11 |
| #2 | Lung-Ji Chen Xiaochuan Chang | 1 |
| #3 | Chen Xiaochuan | 1 |
| #4 | Iwakuma Tomoo | 1 |
| #5 | Cui Yan | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP1562635A2 | Modified dendritic cells | |
| AU2002323895B2 | Combination immunogene compositions | |
| WO0000600A2 | Lentiviral vectors, comprising modified major donor splice sites and major packaging signals | |
| WO9614332A1 | Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats | |
| CA2203499A1 | Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats |